Validation of UBE2C protein as a prognostic marker in node-positive breast cancer
AUTOR(ES)
Loussouarn, D
FONTE
Nature Publishing Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2713693Documentos Relacionados
- Chemotherapy for older women with node-positive breast cancer
- Chemotherapy for older women with node-positive breast cancer
- Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-positive breast cancer (summary of the 2001 update)
- Addition of granulocyte-colony stimulating factor (G-CSF) may further increase chemosensitive state in premenopausal node-positive breast cancer patients with induced angiogenesis after surgery
- Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients